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Abstract: Background and objectives: In addition to conventional healthcare, Ebola survivors are known
to seek traditional and complementary healthcare (T&CM) options to meet their healthcare needs.
However, little is known about the general beliefs of Ebola survivors regarding T&CM and the impact
of these beliefs in influencing their decisions around T&CM use. This study examines Ebola survivors’
attitudes towards T&CM use in Sierra Leone. Materials and Methods: We conducted a nationwide
quantitative cross-sectional study of 358 Ebola survivors in Sierra Leone between January and August
2018. We used descriptive analysis, chi-square tests and backward stepwise binary logistic regression
for data analysis. Results: Close to half of the survivors (n = 163, 45.5%) had used T&CM since their
discharge from an Ebola treatment centre. Survivors who viewed T&CM as boosting their immune
system/resistance were 3.89 times (95%CI: 1.57–9.63, p = 0.003) more likely to use T&CM than those
who did not view T&CM as boosting their immune system/resistance. Additionally, survivors who
viewed T&CM as having fewer side effects than conventional medicine were more likely to use
T&CM [OR = 5.03 (95%CI: 1.92–13.19, p = 0.001)]. Ebola survivors were more influenced to use
T&CM based on their personal experience of the effectiveness of T&CM than by clinical evidence
[OR = 13.72 (95%CI: 6.10–30.84, P < 0.001)]. Ebola survivors who perceived T&CM as providing them
with more control than conventional medicine over their health/body were more likely to use T&CM
[OR = 4.15 (95%CI: 1.74–9.89, p = 0.001)] as opposed to those who did not perceive T&CM in this
way. Conclusions: Considering the widespread use of T&CM, an understanding of Ebola survivors’
attitudes/beliefs towards T&CM is useful to healthcare providers and policymakers with regard
to public education and practitioner–survivors communication, T&CM regulation and research in
Sierra Leone. Ebola survivors appear to turn to T&CM not only for treatment, but also to fill gaps in
conventional health care services.
Keywords: Ebola; Ebola survivors; attitude; beliefs; traditional medicine; complementary medicine;
Sierra Leone
1. Introduction
Traditional and complementary medicine (T&CM) can be defined as a set of healthcare modalities
(local or imported products and practices) that are historically located outside the dominant model
of healthcare [1,2]. In Africa, T&CM may include traditional healthcare products and practices
(herbal medicine or products and traditional bone setting) and imported complementary medicine
(acupuncture and massage therapy, yoga naturopathy) [3–5]. T&CM use in Africa is considered a public
health issue primarily due to its widespread use alone or alongside conventional medicine, with most
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studies showing more than half the population using T&CM [4]. In Sierra Leone, high use of T&CM,
especially herbal medicines use, has been observed among pregnant women [6], lactating mothers [7],
hypertensive patients [8], infertile women [9], healthcare students [10] and for the treatment of malaria
in children [11] and adults [12].
The 2014–2016 Ebola virus disease (EVD) outbreak in West Africa was considered to be the most
significant outbreak in history with EVD infecting 28,616 people and resulting in 11,310 deaths [13].
The outbreak also produced the highest number of survivors in the three most affected countries of
Sierra Leone, Liberia and Guinea. As of the 12 May 2016, the global estimate of EVD survivors was
approximately 10,000 [14]. This number will increase as EVD outbreaks continue in other countries
such in the Democratic Republic of Congo (DR Congo) [15]. Survivors of EVD outbreaks experience
a myriad of post-ebola physical and psychological complications, which include musculoskeletal
pain, ocular and auditory problems, depression, anxiety, fatigue, insomnia, as well as stigma and
discrimination from the community [16–18]. Ebola survivors are known to seek conventional care
to address their myriad health challenges [19,20] and there is evidence of EVD survivors employing
local cultural practices (which encompass T&CM) in their management of EVD transmission and
prevention [21–23]. However, no research to date has evaluated the frequency and reasons for T&CM
use among Ebola survivors.
Two dominant sets of interpretations have been proposed to help explain the reasons why many
people around the globe use T&CM. The first set of interpretations can loosely be referred to as
pull factors, which focused on those features, and factors around T&CM that are attractive to users
(pull factors). These pull factors regarding T&CM use that have been identified in the contemporary
literature across sub-Saharan Africa suggest that people tend to be attracted to T&CM due to its
perceived low cost, availability, congruence with their individual’s cultural and religious beliefs, patient
sense of autonomy over their health and their perceived safety and efficacy of T&CM products [4].
The second interpretation relates to people who are dissatisfied with what conventional medicine
can offer (push factors). The contemporary literature across sub-Saharan Africa suggests that people
seek T&CM due to disenchantment with conventional medicine, the negative attitude of healthcare
providers to cultural traditions (including T&CM), drug availability, long distance to and inequity in
accessing health facilities as well as long waiting times [4]. In addition, beliefs related to safety, efficacy,
holism and the sense of control of one’s health have been identified as possible predictors of T&CM
use among different illness groups outside of Africa [24–27].
The very few studies that have explored beliefs and attitudes towards the use of T&CM in Sierra
Leone have been restricted to healthcare students (showing generally positive attitudes towards T&CM
amongst this sub-group) [10,28]. Given that unpublished data has suggested Ebola survivors are likely
to seek T&CM healthcare in Sierra Leone to help meet their healthcare needs [29], it is important
to examine Ebola survivors’ general beliefs regarding T&CM and how these beliefs are linked with
their decision to use T&CM. Such information is important, as it will help healthcare providers and
policymakers to understand better Ebola survivors’ use and motivations for using T&CM, which will
help minimise risks to patient care and invariably maximize patient care outcomes. These studies may
also serve to identify ‘push’ and ‘pull’ factors that can help design more responsive health services
for Ebola survivors. However, to date, no study in Sierra Leone or across Africa has evaluated Ebola
survivors’ attitudes towards the use of T&CM. To fill this significant research gap, our study evaluates
Ebola survivors’ attitudes towards the use of T&CM in Sierra Leone drawing upon a nationally
representative sample.
2. Materials and Methods
2.1. Study Design, Setting and Participants
A descriptive nationwide questionnaire survey employing a cross-sectional study design was
administered to Ebola survivors who were at least 18 years old and experiencing post-Ebola sequelae in
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Sierra Leone. The study was undertaken between January and August 2018. Ebola survivors who were
unable to accurately provide information or participate in the study due to physical and psychological
conditions such as memory loss, hearing loss, high fever and bleeding or those experiencing acute
emotional distress that would put the research and other participants at risk were excluded.
2.2. Sampling Method
We collected data from the four geographic regions of Sierra Leone (Western Area, Northern
province, Southern province and Eastern province). We then purposefully selected five districts to
cover all four geographic regions of the country. Figure 1 shows the location of the five districts in
Sierra Leone. The five districts include western area urban and western area rural districts (both in the
Western area), Bo district (Southern province), Kenema district (Eastern province) and Bombali district
(Northern province). We chose these five districts based on the epidemiological profile of the total
confirmed Ebola cases and because they are host to the highest number of Ebola survivors in Sierra
Leone. We then randomly selected Ebola survivors in each of the five districts based on proportional
representation using the national list of registered Ebola survivors obtained from the Sierra Leone
Association of Ebola survivors (SLAES). Survivors who were randomly selected were approached to
participate in the study via telephone. The required sample of 351 Ebola survivors was determined
using the formula for cross-sectional study (N = z2pq/d2), with the perceived prevalence (p) assumed
to be 50% since no previous research on T&CM use among Ebola survivors has been conducted so far.
To increase the statistical power, we aimed to recruit 400 Ebola survivors.
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Figure 1. Location of the five sampled districts (Bo District, Kenema District, Bombali District, Western
Area Urban District and Western Area Rural District) in Sierra Leone.
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2.3. Use of Traditional, Complementary and Alternative Medicine
Ebola survivors were questioned about their use of T&CM (product and practitioners) since
their discharge from an Ebola treatment centre for the management of common post-ebola sequelae.
The T&CM products and practices considered in our study included herbal medicine, traditional
medicine practice (traditional bone-setting), prayer/faith healing and massage. The T&CM products
and practices considered in our study were informed by the results of previous research on T&CM use
conducted in Sierra Leone [6–9,12,28] and across Africa [4].
2.4. Attitudes Towards the Use of T&CM among Ebola Survivors
Ebola survivors were asked whether they agree or disagree with the following statements: T&CM
has fewer side effects than conventional medicine (CM); T&CM is more natural than CM; T&CM
promotes a holistic approach to health; T&CM boosts my immune system/resistance; T&CM gives
me more control over my health/body; knowledge about the evidence of T&CM is important to me
as a patient; my personal experience of the effectiveness of T&CM is more important than clinical
evidence; CAM needs to be tested for safety and side-effects; and T&CM is a better preventative
measure than conventional medicine. Survivors were also questioned as to whether they perceived
T&CM practitioners as spending a longer time in consultation with and providing more support to
their patient than medical doctors. Further, we asked survivors about whether they find it easier to
talk to a T&CM practitioner compared to a medical doctor and whether they believe medical doctors
should be able to advise patients about T&CM.
2.5. Data Collection and Ethical Consideration
Ethical approval was obtained from the University of Technology Sydney Human Research
Ethics Committee (UTS-HREC-ETH17-2080, Date of Approval = 19 April 2018) and the Sierra Leone
Ethics and Scientific Review Committee (Date of Approval = 17 May 2018). The selected sample
of Ebola survivors was approached to take part in the study via telephone during which the scope
and rationale, as well as the option to opt out of the study, were explained. Initial verbal consent
was obtained via telephone. For those who gave verbal consent, an arrangement was made either to
fill the questionnaire or to be interviewed at their homes, courtyard or the regional Ebola survivor
office. A participant information sheet that explains the purpose and scope of the study, as well as the
option to opt out, was given or read (for illiterate participants) participants before asked to sign or
thumbprint the consent form. Survivors signing or thumb printing the consent form was interpreted
as their willingness to participate. Survivors who signed or thumbed printed (for illiterate participants)
the consent form were then given the questionnaire to fill or to be interviewed. Data were collected
from Ebola survivors using self-administered or interviewer-administered (for illiterate participants)
formats. Among those who consented to participate in the study, the majority filled the questionnaire
in the presence of a data collector or were interviewed by a data collector at the Ebola survivor regional
office. Additionally, some Ebola survivors filled the questionnaire alone in their homes at their own
time and later sent the filled questionnaires to their regional offices. In addition, some Ebola survivors
filled the questionnaire in the presence of a data collector or were interviewed at their homes or the
village courtyard. We collected our data between May and August 2018.
2.6. Statistical Analysis
Data analysis was conducted using SPSS Statistics version 24. Chi-square or Fischer exact two-tailed
tests were used to determine the association between each of the attitude statements and T&CM use.
We employed a backward stepwise binary logistic model to determine the attitude statements that
are significant predictors of T&CM use. All attitude statements were entered into the model, and
a backward stepwise elimination process was conducted until we obtained the most parsimonious model.
Ebola survivors’ age, sex, marital status, educational background, financial status, religious affiliation,
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perceived health status, place of residence, duration (months) since discharged from ETC and presence
of chronic disease prior to being infected with Ebola were entered into the model as potential cofounders.
The probability value of less than 0.05 was considered statistically significant for all analyses.
3. Results
Of the 400 Ebola survivors invited to participate, 376 consented, of which 358 fully completed the
questionnaire. Table 1 shows the demographic and health-related characteristics between users and
non-users of T&CM among Ebola survivors. More than half Ebola survivors were between the ages of
18–34 years (n = 194, 54.2%) and close to two thirds were females (n = 223, 62.3%). Moreover, close to
three-quarters perceived their current health to be fair/poor (n = 262, 73.2%).





18–33 years 194 (54.2)
34–49 years 134 (37.4)























Northern region (Bambali district) 120 (33.5)
Southern region (Bo district) 55 (15.4)
Eastern region (Kenema district) 62 (17.3)
Western Area 121 (33.8)
Current Perceived Health Status
Very good/Good 96 (26.8)
Fair/poor 262 (73.2)
Duration (Months) since Discharged from ETC ≤3 years 27 (7.5)




Table 2 shows that close to half of the survivors (n = 163, 45.5%) had used T&CM since their
discharge from an Ebola treatment centre. Moreover, less than a quarter of survivors (n = 62, 17.3%)
used both conventional medicine and T&CM concurrently. Herbal medicine (n = 136, 83.4%) is the
most common type of T&CM used among T&CM users.
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Table 2. Traditional and complementary healthcare (T&CM) utilization among Ebola survivors (n = 358).
T&CM Utilization Variable n (%)
Users 163 (45.5)
Non-user 195 (54.5)
Concurrent use of both
conventional medicine and T&CM
Yes 62 (17.3)
No 296 (82.7)
Types of T&CM use—multiple
choice
Herbal medicine 136 (83.4)
Animal Extract 23 (14.1)
Prayer/faith healing 60 (36.8)
Acupuncture 1 (0.6%)
Massage 33 (20.2)
Others (scarification local surgery) 10 (6.1)
Average monthly direct cost of
T&CM per person
= Le 14,036 approximately 1.8
US dollars (0 to 10.9 USD)
Table 3 shows the attitudes towards use of T&CM by Ebola survivors. More than two thirds of
participants (n = 257, 71.8%) believe that T&CM is ‘natural’. Approximately three-quarters of survivors
are of the view that T&CM needs to be tested for safety/side-effects and more than half (n = 213, 59.5%)
report knowledge about the evidence of T&CM as important to them. In addition, the majority of
Ebola survivors (n = 313, 87.4%) believe medical doctors should be able to advise patients about T&CM.
On the other hand, more than half (n = 218, 60.9%) did not perceive T&CM as having fewer side effects
than conventional medicine. Furthermore, more than two thirds (n = 250, 69.8%) did not perceive
T&CM as promoting a holistic approach to health. In addition, less than one quarter (n = 73, 20.4%)
perceived a T&CM practitioner as providing more support to their patients than a medical doctor.
Table 3. Attitude of Ebola survivors towards the use of T&CM.
Attitude of Ebola Survivors towards the Use of T&CM
Agree Neutral Disagree
n (%) n (%) n (%)
T&CM is a more natural than conventional medicine 257 (71.8) 20 (5.6) 81 (22.6)
TCAM boosts my immune system/resistance 114 (31.8) 44 (12.3) 200 (55.9)
T&CM has fewer side-effects than conventional medicine 82 (22.9) 58 (16.2) 218 (60.9)
T&CM promotes a holistic approach to health 100 (27.9) 55 (15.4) 203 (56.7)
T&CM gives me more control over my health/body 120 (33.5) 78 (21.8) 160 (44.7)
Knowledge about the evidence of T&CM effectiveness is important to
me as a patient 213 (59.5) 25 (7.0) 120 (33.5)
My personal experience of the effectiveness of T&CM is more
important than clinical evidence 163 (45.5) 36 (10.1) 159 (44.4)
T&CM is a better preventative measure than conventional medicine 58 (16.2) 50 (14.0) 250 (69.8)
T&CM needs to be tested for safety/side-effects 268 (74.9) 27 (7.5) 63 (17.6)
T&CM practitioner spends a longer time with patients in
consultations compared with a medical doctor 177 (49.4) 47 (13.1) 134 (37.4)
T&CM practitioner provides more support to his/her patient than
a medical doctor 73 (20.4) 47 (13.1) 238 (66.5)
I find it easier to talk to a T&CM practitioner than a medical doctor 100 (27.9) 33 (9.2) 225 (62.8)
Medical doctors should be able to advise patient about T&CM 313 (87.4) 16 (4.5) 29 (8.1)
Table 4 outlines the association between T&CM use and individual attitudes of Ebola survivors.
Attitude statements such as T&CM is more natural than conventional medicine (p < 0.001), T&CM
boosts my immune system/resistance (p < 0.001), my personal experience of the effectiveness of T&CM
is more important than clinical evidence (p < 0.001), T&CM gives me more control over my health/body
(p < 0.001), I find it easier to talk to a T&CM practitioner than a medical doctor (p < 0.001) and T&CM has
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fewer side-effects than conventional medicine (p < 0.001) are associated with T&CM use. No statistical
difference was observed between T&CM users and non-users for the remaining attitude statements.




n (%) n (%)
T&CM is a more natural than conventional
medicine
Disagree 10 (6.1) 71 (36.4)
<0.001Neutral 6 (3.7) 14 (7.2)
Agree 147 (90.2) 110 (56.4)
T&CM boosts my immune system/resistance
Disagree 46 (28.2) 154 (79.0)
<0.001Neutral 14 (8.6) 30 (15.4)
Agree 103 (63.2) 11 (5.6)
T&CM has fewer side-effects than conventional
medicine
Disagree 69 (42.3) 149 (76.4)
<0.001Neutral 30 (18.4) 28 (14.4)
Agree 64 (39.3) 18 (9.2)
T&CM promotes a holistic approach to health
Disagree 60 (36.8) 143 (73.3)
<0.001Neutral 23 (14.1) 32 (16.4)
Agree 80 (49.1) 20 (10.3)
T&CM gives me more control over my
health/body
Disagree 39 (23.9) 121 (62.1)
<0.001Neutral 28 (17.2) 50 (25.6)
Agree 96 (58.9) 24 (12.3)
Knowledge about the evidence of T&CM is
important to me as a patient
Disagree 18 (11.0) 102 (52.3)
<0.001Neutral 3 (1.8) 22 (11.3)
Agree 142 (87.1) 71 (36.4)
My personal experience of the effectiveness of
T&CM is more important than clinical evidence
Disagree 19 (11.7) 140 (71.8)
<0.001Neutral 11 (6.7) 25 (12.8)
Agree 133 (81.6) 30 (15.4)
T&CM is a better preventative measure than
conventional medicine
Disagree 87 (53.4) 163 (83.6)
<0.001Neutral 24 (14.7) 26 (13.3)
Agree 52 (31.9) 6 (3.1)
T&CM needs to be tested for safety/side-effects
Disagree 30 (18.4) 33 (16.9)
0.409Neutral 9 (5.5) 18 (9.2)
Agree 124 (76.1) 144 (73.8)
T&CM practitioner spends a longer time with
patients in consultations compared with a
medical doctor
Disagree 59 (36.2) 75 (38.5)
0.257Neutral 17 (10.4) 30 (15.4)
Agree 87 (53.4) 90 (46.2)
T&CM practitioner provides more support to
his/her patient than a medical doctor
Disagree 87 (53.4) 151 (77.4)
<0.001Neutral 20 (12.3) 27 (13.8)
Agree 56 (34.4) 17 (8.7)
I find it easier to talk to a T&CM practitioner
than a medical doctor
Disagree 78 (47.9) 147 (75.4)
<0.001Neutral 13 (8.0) 20 (10.3)
Agree 72 (44.2) 28 (14.4)
Medical doctors should be able to advise
patient about T&CM
Disagree 13 (8.0) 16 (8.2)
0.496Neutral 5 (3.1) 11 (5.6)
Agree 145 (89.0) 168 (86.2)
Backward stepwise logistic regression (Table 5) found that survivors who agreed that T&CM
boosts their immune system/resistance were 3.89 (95%CI: 1.57–9.63, p = 0.003) times more likely to
use T&CM than those that disagreed. Ebola survivors who agreed with the statement that T&CM has
fewer side effects than CM were 5.03 (95%CI: 1.92–13.19, p = 0.001) times more likely to use T&CM
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than those who disagreed. Ebola survivors were 13.72 (95%CI: 6.10–30.84, p < 0.001) times more likely
to use T&CM if they considered important their personal experience of the effectiveness of T&CM than
clinical evidence. In addition, survivors who believe that T&CM gives them more control over their
health/body were 4.15 (95%CI: 1.74–9.89, p = 0.001) times more likely to be T&CM users as opposed to
those who disagreed with this statement.
Table 5. Logistic regression analyses demonstrating attitudes towards T&CM and use of TCAM
treatment among Ebola survivors.
Attitude Statements Variables
T&CM Treatment Use
Adjusted OR 95% C.I. p-Value
T&CM boosts my immune system/resistance
Disagree 1
Neutral 0.83 0.29–2.39 0.729
Agree 3.89 1.57–9.63 0.003
T&CM has fewer side-effects than conventional
medicine
Disagree 1
Neutral 1.92 0.73–5.08 0.189
Agree 5.03 1.92–13.19 0.001
T&CM gives me more control over my health/body
Disagree 1
Neutral 1.68 0.68–4.20 0.263
Agree 4.15 1.74–9.89 0.001
My personal experience of the effectiveness of
T&CM is more important than clinical evidence
Disagree 1
Neutral 2.07 0.58–7.41 0.263
Agree 13.72 6.10–30.84 <0.001
Note: C.I. =Confidence Interval; OR= Odd ratio.
4. Discussion
Our paper presents findings from the first nationwide study to examine Ebola survivors’ attitudes
towards the use of T&CM in Sierra Leone. Ebola survivors who use T&CM appear to be of the view
that these medicines boost their immune system. Similar reasons have been proffered for using T&CM
among those with HIV/AIDS [30] and cancer survivors [31]. The appeal of T&CM to boosting immunity
among users in our study may be explained in that, an individual’s health is a function of his/her immune
status, which is in line with T&CM philosophies that disease should be managed by challenging the
body to heal itself rather than focusing on symptomatic treatment [32].
Additionally, based on the results of this study this group of Ebola survivors may be of the
view that the mechanism underlying the pathophysiology of most of their post-ebola sequalae is
thought to be immune mediated [33–35] and that the use of certain T&CM with immunomodulatory
properties will help manage their post-Ebola complications. This is perhaps unsurprising given the
infectious nature of the viral disease that caused the acute episode. Although several T&CM approaches
are reported to exert immunological changes in preclinical and clinical studies [36], thus far, these
studies have employed relatively insensitive and straightforward methodologies that render findings
inconclusive. Methodologically robust clinical studies that use newer and more powerful technologies
(magnetic-resonance imaging and positron-emission tomography and microarray analyses) are required
to provide strong evidence on the immunomodulatory effect of T&CM that might be of use in the
management of post-Ebola sequelae among survivors.
Our analyses also shows Ebola survivors who are T&CM users hold the view that T&CM has
fewer side effects than conventional medicine mirroring similar findings in the literature on T&CM
use among HIV/AIDS patients [37] and individuals with musculoskeletal conditions within [38] and
outside [25] of Africa. Moreover, our analysis suggests that Ebola survivors who use T&CM are highly
likely to be driven by belief in the notion that T&CM is more natural than conventional medicine.
The assumption that T&CM treatments are natural and therefore non-toxic have been found to be
associated with people’s decisions to use T&CM in multiple studies in multiple conditions [4,24,39].
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T&CM methods and remedies are considered natural and organic as opposed to conventional medicine,
which is often thought of as artificial and/or synthetic [24].
Although some T&CM products and practices have been found to be relatively effective and safe,
the safety of T&CM in general is still a debatable area—particularly in a nascent condition such as
post-Ebola sequelae—as there is insufficient scientific evidence to prove that T&CM is of less risk
than conventional medicine [40]. Information regarding the safety of T&CM is mostly derived from
community use and are—in most cases—not reliable [41,42]. It is important that well-designed studies
provide more examination of such beliefs around safety and T&CM both in the general population and
among Ebola survivors.
To further understand T&CM safety, it is also important for researchers to take into consideration
the fact that the risk of T&CM needs to be viewed through a wider lens of missed opportunity for
known safe and effective treatments, or following advice from poorly trained health professionals in
an unregulated environment [43]. Findings from studies such as ours can inform regulatory and policy
frameworks, the designing of public health messages and the nature of provider-patient communication
regarding T&CM use; all geared towards ensuring safe and informed care for Ebola survivors.
Our study results also indicate that Ebola survivors who use T&CM were concerned more with
their personal experience of T&CM effectiveness than with clinical evidence, which is congruent
with findings from studies of T&CM use among cancer survivors [44,45] and pregnant women [27].
The absence of clinical evidence of effectiveness and safety of the commonly used T&CM in the
general population and among Ebola survivors in Sierra Leone, and coupled with the notion that
T&CM is inherently safe and effective may help explain their preference for personal experience
of T&CM over clinical evidence. While few preclinical efficacy [46,47] and toxicity [48] studies of
some medicinal plants considered traditional medicine have been conducted in Sierra Leone, clinical
research examining the safety and efficacy of commonly used T&CM especially herbal medicines in
Sierra Leone is lacking. The availability of scientific evidence of T&CM effectiveness and safety is
important in ensuring that it is effectively used. T&CM users are known to assume that T&CM is safe
and effective [4] and that their decision to use T&CM is informed by non-professionals sources [42].
Therefore, it is imperative that robust efficacy and safety studies (preclinical, clinical and post-market
surveillance) are conducted on commonly used T&CM in Sierra Leone that will inform personal and
clinical decision making with regards T&CM.
Our study finding that survivors who are T&CM users want more control over their health
is in line with insights from the current post-infectious sequelae literature both within [4,49] and
outside [25] of Africa, including those among survivors of severe acute respiratory syndrome (SARS)
in Hong Kong [50]. The sense of fear, vulnerability and perceived loss of control over their health due
to the physical, psychosocial and economic problems experienced by Ebola survivors [18,51,52] may be
a source of attraction toward T&CM. This may be particularly in view of the failures of conventional
health options to address these needs, which allows survivors to have the sense of control, autonomy
and active participation in decisions regarding their health and wellbeing [24–26,49].
T&CM is perceived to allow patients to take ownership of their health and well-being by allowing
them to actively seek information and make decisions about treatment modalities that prove to be
beneficial without being instructed on what to do [26,53]. Ebola survivors’ sense of control on one
hand may affect their willingness to disclose their T&CM use status to their healthcare provider as
disclosure of T&CM may be perceived by patients as shifting the power to their healthcare provider
to make health decisions for them [53]. On the other hand, the sense of control that T&CM provides
may also make survivors more assertive and therefore more communicative with their healthcare
provider [53]. Notwithstanding, it is important that healthcare providers proactively seek to ask about
survivors’ possible T&CM use as decisions regarding the efficacy and safety of T&CM often fail to be
informed by reliable information sources [42], and such use may be indicative of unmet needs.
The majority of T&CM users and non-users amongst the Ebola survivors in our study agreed that
medical doctors should be able to advise their patients about T&CM. Although this is in contrast to
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some studies in other conditions and in other countries [27], our finding suggests that Ebola survivors
in Sierra Leone regardless of their T&CM use status will prefer to get advice about T&CM from
a conventional medicine provider. The expectation of Ebola survivors for conventional medicine
practitioners to be able to provide advice on T&CM illustrates a potential need for healthcare providers
to routinely initiate and incorporate discussions about T&CM during consultation with Ebola survivors.
The provision of evidence-based information on T&CM to patients requires healthcare providers to be
knowledgeable about the safety and efficacy of commonly used T&CM among Ebola survivors.
Study Limitations
One limitation of our study is that the data collected is self-reported, which may reflect recall
bias. Moreover, our findings are not necessarily representative of the perceptions and experiences of
Ebola survivors in other countries. Also, due to the cross-sectional nature of our study, a cause-effect
relationship cannot be deduced from our results. In addition, we excluded Ebola survivors in our study
with conditions that limit their ability to accurately provide information or participate in the study and
may put the research and other participants at risk. Although the demographic characteristics of Ebola
survivors excluded are similar to those included in our study, those excluded may have held different
views with regards to the attitude statements considered in our study.
5. Conclusions
Findings from our study have provided insights into the reasons for T&CM use among Ebola
survivors in Sierra Leone. Ebola survivors who are T&CM users value safety, personal experience of
effectiveness, patient autonomy and the need to boost the body’s immunity when using T&CM. Such
reasons for T&CM use among Ebola survivors are useful to conventional health providers, in improving
practitioner-patient communication regarding T&CM and identify survivors’ beliefs about T&CM that
might be targets for public education among Ebola survivors by policymakers and health providers.
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